Brokerage firm Motilal Oswal recommended buying the stock of Ajanta Pharma (AJP) for a 29% return. The firm thinks that the company's Branded Generics segment in Asia and Africa remains on a robust footing on the back of launches and market share gains in existing products.
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/bsc4t5v
via IFTTT
from Tax Saving Investments | Tax Saving Tips & News | Income Tax India – Oneindia Money https://ift.tt/bsc4t5v
via IFTTT